SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/25AAC8B828C85049911A75D4D9A53F5A96EFA188BF5897D060A7361D6D509611BB803FB5CBCC8CA954A5B05B71C91C2C>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/25AAC8B828C85049911A75D4D9A53F5A96EFA188BF5897D060A7361D6D509611BB803FB5CBCC8CA954A5B05B71C91C2C
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/25AAC8B828C85049911A75D4D9A53F5A96EFA188BF5897D060A7361D6D509611BB803FB5CBCC8CA954A5B05B71C91C2C
http://www.w3.org/2000/01/rdf-schema#comment
"Data show that 11/105 patients failed all molecular analysis: no mutations in oncogenes EGFR KRAS and NRAS were detected and no ALK gene rearrangements or MET gene amplifications were identified."
xsd:string
http://purl.uniprot.org/uniprot/#_FE08F340286CD3F88B0FA55F445DCC6A283B7B8E3FBF84952D464CD6EF985AC8597A3C274F77B11C6C2BE8B91016BF52
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/25AAC8B828C85049911A75D4D9A53F5A96EFA188BF5897D060A7361D6D509611BB803FB5CBCC8CA954A5B05B71C91C2C
http://purl.uniprot.org/uniprot/E2I6F5
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/25AAC8B828C85049911A75D4D9A53F5A96EFA188BF5897D060A7361D6D509611BB803FB5CBCC8CA954A5B05B71C91C2C
http://purl.uniprot.org/uniprot/#_E2I6F5-mappedCitation-26581482
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/25AAC8B828C85049911A75D4D9A53F5A96EFA188BF5897D060A7361D6D509611BB803FB5CBCC8CA954A5B05B71C91C2C